TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Micro-X Ltd. ( (AU:MX1) ) has shared an announcement.
Micro-X Ltd has been awarded a $4.4 million grant by the Australian Government’s Industry Growth Program to develop and trial a stroke-capable ambulance equipped with their Head CT device. This initiative aims to revolutionize emergency stroke care by enabling faster diagnosis and treatment through in-ambulance imaging, potentially setting a new global standard. The project involves collaboration with the South Australian Ambulance Service and Royal Adelaide Hospital, and it will include developing new protocols and training for paramedics. The trial will serve as a global case study and support regulatory submissions for the Head CT device, with implications for improved health equity and stroke recovery rates worldwide.
The most recent analyst rating on (AU:MX1) stock is a Buy with a A$0.17 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.
More about Micro-X Ltd.
Micro-X Ltd is an Australian hi-tech company specializing in cold cathode X-ray technology for health and security markets globally. The company focuses on developing innovative medical imaging solutions, including portable CT scanners, to enhance healthcare delivery and improve patient outcomes.
Average Trading Volume: 382,354
Technical Sentiment Signal: Buy
Current Market Cap: A$52.76M
See more insights into MX1 stock on TipRanks’ Stock Analysis page.